Form 8-K

8-K — Calisa Acquisition Corp

Accession: 0001493152-26-043574

Filed: 2026-09-21

Period: 2026-09-15

CIK: 0002026767

SIC: 7374 (SERVICES-COMPUTER PROCESSING & DATA PREPARATION)

Item: Entry into a Material Definitive Agreement

Item: Financial Statements and Exhibits

Documents

8-K — form8-k.htm (Primary)

EX-10.1 (ex10-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: form8-k.htm · Sequence: 1

false

0002026767

2026-09-15

0002026767

ALIS:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember

2026-09-15

0002026767

ALIS:OrdinarySharesParValue0.000075PerShareMember

2026-09-15

0002026767

ALIS:RightsEachEntitlingHolderToOneTenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember

2026-09-15

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

WASHINGTON,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES

EXCHANGE ACT OF 1934

Date

of Report (Date of earliest event reported): September 15, 2026

CALISA

ACQUISITION CORP

(Exact

Name of Registrant as Specified in Charter)

Cayman

Islands

001-42910

00-0000000 N/A

(State

or Other Jurisdiction

(Commission

(IRS

Employer

Incorporation)

File

Number)

Identification

No.)

205

W. 37th Street

New

York, NY 10018

(Address

of Principal Executive Offices) (Zip Code)

(203)

998-5540

(Registrant’s

Telephone Number, Including Area Code)

Not

Applicable

(Former

Name or Former Address, if Changed Since Last Report)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under

any of the following provisions (see General Instruction A.2. below):

☒

Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to section 12(b) of the Act:

Title

of Each Class

Trading

Symbol(s)

Name

of each exchange on which registered

Units,

each consisting of one ordinary share and one right

ALISU

The

Nasdaq Stock Market LLC

Ordinary

Shares, par value $0.000075 per share

ALIS

The

Nasdaq Stock Market LLC

Rights,

each entitling the holder to one tenth of one ordinary share upon the completion of the Company’s initial business combination

ALISR

The

Nasdaq Stock Market LLC

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405

of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ☒

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

1.01. Entry into a Material Definitive Agreement.

September 15, 2026, Calisa Acquisition Corp, a Cayman Islands exempted company (the “Company”), Goodvision AI Inc., a Cayman

Islands exempted company (“Goodvision”), and the funds, accounts and/or other investment vehicles managed by Harraden Circle

Investments, LLC signatory thereto (collectively, the “Purchaser”), entered into a Prepaid Forward Purchase Agreement (the

“FPA”). As previously disclosed, the Company, Calisa Merger Sub, a Cayman Islands exempted company and a direct, wholly owned

subsidiary of the Company (“Merger Sub”), and Goodvision are parties to a Business Combination Agreement, dated as of March

6, 2026 (as amended, the “Business Combination Agreement”), pursuant to which Merger Sub will merge with and into Goodvision,

with Goodvision surviving the merger as a direct, wholly owned subsidiary of the Company (the “Business Combination”). The

FPA is intended to potentially maximize the amount of funds retained by the Company following consummation of the Business Combination.

accordance with the FPA and subject to the terms and conditions set forth therein, the Purchaser will purchase from holders of ordinary

shares, par value $0.000075 per share, of the Company (“Ordinary Shares”) up to 3,000,000 Ordinary Shares (such shares to

be purchased, the “Forward Purchase Shares”), at a price per share no greater than the redemption price payable to redeeming

public shareholders of the Company (the “Redemption Price”). The cash held in the Company’s trust account as of August

31, 2026 was approximately $10.31 per public share. The Purchaser will not vote any Ordinary Shares purchased pursuant to the

FPA at the shareholder meeting relating to the Business Combination.

later than the earlier of (a) one business day after the closing of the Business Combination and (b) the date any assets from the Company’s

trust account are disbursed in connection with the Business Combination, the Company will cause the Purchaser to be paid directly, out

of the funds so disbursed, a cash amount (the “Prepayment Amount”) equal to the number of Forward Purchase Shares multiplied

by the Redemption Price. The Company will also reimburse the Purchaser for expenses incurred in connection with the FPA and the purchase

of the Forward Purchase Shares.

the date that is 12 months after the closing of the Business Combination (or such earlier date specified by the Seller) (the “Maturity

Date”), any Forward Purchase Shares not sold by the Purchaser will be returned to the Company, and any remaining amounts in respect

of the Forward Purchase Shares will be retained by the Purchaser, less any amounts then owing to the Company from sales effected prior

to the Maturity Date.

The Seller may

terminate any portion of the FPA earlier than the Maturity Date by notifying the Company of the termination and paying the Company the

then applicable Reset Price. The Reset Price is initially the Redemption Price, but may be adjusted downwards under certain circumstances

as described in the FPA.

The

foregoing description of the FPA is not complete and is qualified in its entirety by reference to the full text of the FPA, a copy of

which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.

Cautionary

Note Regarding Forward Looking Statements

Neither

the Company, Goodvision nor any of their respective affiliates makes any representation or warranty as to the accuracy or completeness

of the information contained in this Current Report on Form 8-K. This Current Report is not intended to be all-inclusive or to contain

all the information that a person may desire in considering the proposed transactions discussed herein, and it is not intended to form

the basis of any investment decision or any other decision in respect of the proposed transactions.

This

Current Report and the exhibits filed or furnished herewith include certain “forward-looking statements” within the meaning

of the federal securities laws with respect to the proposed transaction between the Company and Goodvision. These forward-looking statements

generally are identified by words and phrases such as “aspire,” “expect,” “estimate,” “project,”

“budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,”

“will,” “will be,” “will continue,” “will likely result,” “could,” “should,”

“would,” “believe(s),” “predicts,” “potential,” “continue,” “future,”

“opportunity,” “strategy” and similar expressions. Forward-looking statements are based on current expectations

and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed

or implied by such forward-looking statements.

Factors

that may cause such differences include, among other things, the risk that the benefits of the Business Combination may not be realized;

the risk that the Business Combination may not be completed in a timely manner or at all; the amount of redemption requests made by the

Company’s public shareholders; the failure to satisfy the conditions to the consummation of the Business Combination; the ability

to meet applicable stock exchange listing standards following the Business Combination; the occurrence of any event, change or other

circumstance that could give rise to the termination of the Business Combination Agreement or the FPA; the outcome of any legal proceedings

that may be initiated following announcement of the Business Combination or the FPA; costs related to the Business Combination; changes

in applicable laws or regulations; and other risks and uncertainties described in the Company’s filings with the Securities and

Exchange Commission (“SEC”), including the definitive proxy statement/prospectus described below.

The

Company and Goodvision caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date

made. Neither the Company nor Goodvision undertakes or accepts any obligation to publicly update or revise any forward-looking statements

to reflect any change in expectations or any change in events, conditions or circumstances on which any such statement is based, except

as required by applicable law.

Additional

Information and Where to Find It

connection with the proposed Business Combination, the Company has filed with the SEC a registration statement on Form S-4 (File No.

333-296926), which includes a proxy statement/prospectus (the “Registration Statement”). The Registration Statement was declared

effective by the SEC on September 11, 2026, and the Company has filed the definitive proxy statement/prospectus with the SEC. The Company

also will file other documents regarding the proposed Business Combination with the SEC. This Current Report does not contain all the

information that should be considered concerning the Business Combination and is not intended to form the basis of any investment decision

or any other decision in respect of the Business Combination.

BEFORE

MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS AND SECURITYHOLDERS OF THE COMPANY ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT/PROSPECTUS

AND ALL OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE BUSINESS COMBINATION CAREFULLY BECAUSE THEY

CONTAIN IMPORTANT INFORMATION ABOUT GOODVISION, THE COMPANY, THE BUSINESS COMBINATION AND RELATED MATTERS. Investors and securityholders

may obtain free copies of the definitive proxy statement/prospectus and other documents filed with the SEC by the Company through the

website maintained by the SEC at www.sec.gov. In addition, investors and securityholders may obtain free copies of the documents filed

with the SEC by directing a written request to the Company at 205 W. 37th Street, New York, New York 10018.

Participants

in the Solicitation

The

Company, Goodvision and certain of their respective directors, executive officers and employees may be considered to be participants

in the solicitation of proxies from the Company’s shareholders in connection with the Business Combination. Information regarding

the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the Company’s shareholders in connection

with the Business Combination, including a description of their respective direct and indirect interests, by security holdings or otherwise,

is included in the definitive proxy statement/prospectus. Additional information regarding the Company’s directors and executive

officers can also be found in the Company’s filings with the SEC. These documents are available free of charge as described above.

Offer or Solicitation

This

Current Report on Form 8-K does not constitute (i) a solicitation of a proxy, consent or authorization with respect to any securities

or in respect of the Business Combination, or (ii) an offer to sell or the solicitation of an offer to buy any securities, or a solicitation

of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would

be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall

be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended.

Item

9.01. Financial Statements and Exhibits.

(d)

Exhibits:

Exhibit

No.

Description

10.1

Prepaid Forward Purchase Agreement, dated as of September 15, 2026, by and among Calisa Acquisition Corp, Goodvision AI Inc. and the Purchaser.

104

Cover

Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

Dated:

September 21, 2026

CALISA

ACQUISITION CORP

By:

/s/

Hongfei Zhang

Name:

Hongfei

Zhang

Title:

Chief

Executive Officer

EX-10.1

Filename: ex10-1.htm · Sequence: 2

Exhibit

10.1

Date:

September

15, 2026

To:

Calisa

Acquisition Corp., a Cayman Islands exempted company, which will be renamed Goodvision AI Holding Limited (“ALIS”,

or the “Counterparty”).

Address:

205 W. 37th Street

New York, NY 10018

From:

(i)

Harraden

Circle Investors, LP (“HCI”), (ii) Harraden Circle Special Opportunities, LP (“HCSO”), (iii) Harraden Circle

Strategic Investments, LP (“HCSI”), (iv) Harraden Circle Concentrated, LP (“HCC”) (with HCI, HCSO, HCSI,

HCC collectively as “Seller”)

Re:

Prepaid

Share Forward (the “Transaction”)

The

purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”)

entered into between Seller and the Counterparty on the Trade Date specified below. The term “Counterparty” refers

to ALIS, which will be renamed Goodvision AI Holding Limited following the Business Combination. “Target” refers to

Goodvision AI Inc., a Cayman Islands exempted operating company, prior to the Business Combination (defined below). Certain terms of

the Transaction shall be as set forth in this Confirmation, with additional terms as set forth in a Pricing Date Notice (the “Pricing

Date Notice”) in the form of Schedule A hereto. This Confirmation, together with the Pricing Date Notice, constitutes

a “Confirmation” and the Transaction constitutes a separate “Transaction” as referred to in the ISDA Form (as

defined below).

This

Confirmation, together with the Pricing Date Notice, evidences a complete binding agreement between Seller, Target and Counterparty as

to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous

written or oral communications with respect thereto.

The

2006 ISDA Definitions (the “Swap Definitions”) and the 2002 ISDA Equity Derivatives Definitions (the “Equity

Definitions”, and with the Swap Definitions, the “Definitions”), each as published by the International

Swaps and Derivatives Association, Inc., are incorporated into this Confirmation. If there is any inconsistency between the Definitions

and this Confirmation, this Confirmation governs. If, in relation to the Transaction, there is any inconsistency between the ISDA Form,

this Confirmation (including the Pricing Date Notice), the Swap Definitions and the Equity Definitions, the following will prevail for

purposes of such Transaction in the order of precedence indicated: (i) this Confirmation (including the Pricing Date Notice); (ii) the

Equity Definitions; (iii) the Swap Definitions; and (iv) the ISDA Form.

This

Confirmation, together with the Pricing Date Notice, shall supplement, form a part of, and be subject to an agreement in the form of

the 2002 ISDA Master Agreement (the “ISDA Form”) as if Seller, Target and Counterparty had executed an agreement in

such form (but without any Schedule except as set forth herein under “Schedule Provisions”) on the Trade Date.

The

terms of the particular Transaction to which this Confirmation relates are as follows, and capitalized terms, as used herein and to the

extent not otherwise defined, shall have as their definitions the applicable terms described below:

General

Terms

Type

of Transaction:

Forward Transaction

Trade

Date:

September

15, 2026

Pricing

Date:

The

date specified in the Pricing Date Notice.

Effective

Date:

One

(1) Settlement Cycle following the Pricing Date.

Maturity

Date:

The

earlier to occur of (a) the date that is 12-months after the closing of the transactions between Counterparty and Target (the “Business

Combination”) pursuant to the Business Combination Agreement, dated as of March 6, 2026, between ALIS and the Target (the

“Merger Agreement”), or (b) the date specified by Seller in a written notice to be delivered to Counterparty at

Seller’s sole discretion (which Maturity Date shall not be earlier than the day such notice is effective). The Maturity Date

notice will become effective immediately upon its delivery from Seller to Counterparty in accordance with this Confirmation.

VWAP

Price:

For

any scheduled trading day, the volume weighted average price per Share for such day as reported on the relevant Bloomberg Screen

“GVAI US <Equity> AQR SEC” (or any successor thereto), or if such price is not so reported on such trading day

for any reason or is erroneous, the VWAP Price shall be as reasonably determined by the Calculation Agent.

Pricing

Date Notice:

Seller

shall deliver to Counterparty the Pricing Date Notice no later than one (1) business day in which Nasdaq and commercial banks in

the City of New York are open for business (each such day an “Exchange Business Day”) following the closing of

the Business Combination. The Pricing Date Notice shall include the Number of Shares subject to this Confirmation.

Seller:

Seller.

Buyer:

Counterparty.

Prior

to the closing of the Business Combination, the ordinary shares, par value $0.000075 per share, of Calisa Acquisition Corp., a Cayman

Island exempted company (Ticker: “ALIS”) and after the Business Combination, the Class A ordinary shares, par

value $0.000075 per share, of Goodvision AI Holding Limited, a Cayman Islands exempted company (Ticker: “GVAI”).

Number

of Shares:

The

number of Recycled Shares, but in no event more than the Maximum Number of Shares. The Number of Shares is subject to reduction as

described under “Optional Early Termination”.

Maximum

Number of Shares:

3,000,000

Shares.

Recycled

number of free trading Shares (such Shares referred to herein as the “Public Shares”)

equal to the number of Shares purchased by Seller from third parties (other than Counterparty)

through a broker in the open market (other than through Counterparty); provided that Seller

shall have irrevocably waived all redemption rights with respect to such Shares as provided

below in the section captioned “Transactions by Seller in the Shares.” Seller

shall specify the number of Recycled Shares (the “Number of Recycled Shares”)

in the initial Pricing Date Notice.

Initial

Price:

The

redemption price in accordance with the organizational/constitutive documents of the Counterparty (the “Redemption Price”).

Reset

Price:

The

Reset Price will initially be the Initial Price. From time to time in the Counterparty’s sole discretion, the Reset Price may

be adjusted to the lower of the current Reset Price and the average daily VWAP over the prior 5 trading days. The Reset Price shall

be subject to reduction upon a Dilutive Offering Reset immediately upon the occurrence of such Dilutive Offering. For avoidance of

doubt the Reset Price may only be adjusted downward. Notwithstanding the foregoing, the Reset Price will in no event be less than

$4.00 per Share (subject to adjustment for stock splits, stock dividends, recapitalizations and other similar structural changes).

Dilutive

Offering Reset:

the extent the Counterparty closes any agreement to sell or grants any right to reprice, or otherwise disposes of or issues (or announce

any offer, sale, grant or any option to purchase or other disposition) any Shares or any securities of the Counterparty or any of

its respective subsidiaries (but for the avoidance of doubt, excluding any secondary transfers), which would entitle the holder thereof

to acquire or sell on behalf of the Counterparty at any time Shares or other securities of the Counterparty, including, without limitation,

any debt, preferred stock, preference shares, right, option, warrant or other instrument that is at any time convertible into or

exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Shares or other securities of the Counterparty,

at an effective price per share less than the then existing Reset Price (a “Dilutive Offering”), then the Reset

Price shall be modified to equal such reduced price as of such date; provided that, without limiting the foregoing, a Dilutive Offering

Reset (for the avoidance of doubt) (i) shall include any Equity Line of Credit or other similar financing entered into after the

date of this Agreement, (ii) shall not include the grant, issuance or exercise of employee stock options or other equity awards under

the Counterparty’s equity compensation plans or Shares underlying warrants now outstanding or issued in connection with the

Business Combination, (iii) shall not include Shares issued in connection with the Business Combination pursuant to the Merger Agreement

or in connection with the private placement to be consummated concurrently or immediately prior to the consummation of the Business

Combination, or (iv) shall not include any Shares or other securities convertible or exercisable for Shares issued pursuant to any

other acquisition, merger or similar transaction by the Counterparty.

Prepayment:

Payment

of the Prepayment Amount shall be made directly from the Counterparty’s Trust Account

maintained by Continental Stock Transfer & Trust Company holding the net proceeds of

the sale of the units in Counterparty’s initial public offering (the “Trust

Account”) no later than the Prepayment Date.

Counterparty

shall provide (a) notice to Counterparty’s trustee of the entry into this Confirmation no later than one (1) Local Business

Day following the date hereof, with copy to Seller and Seller’s outside legal counsel, and (b) to Seller and Seller’s

outside legal counsel a final draft of the flow of funds from the Trust Account prior to the closing of the Business Combination

itemizing the Prepayment Amount due; provided that Seller shall be invited to attend any closing call in connection with the Business

Combination.

Prepayment

Amount:

the close of the Business Combination, the Counterparty will pay to the Seller an amount equal to the (i) Number of Shares, multiplied

by (ii) the Initial Price (“Prepayment Amount”).

Prepayment

Date:

The

earlier of (a) one (1) Local Business Day after the closing of the Business Combination and (b) the date any assets from the Trust

Account are disbursed in connection with the Business Combination.

Variable

Obligation:

Not

applicable.

Redemptions:

Counterparty

shall promptly accept any redemption reversal requests in connection with purchases of Shares by Seller for any Public Shares subject

to this Confirmation.

Exchange(s):

The

Nasdaq Stock Market LLC (“Nasdaq”).

Exchange(s):

All

Exchanges.

Reimbursement

of Legal Fees and Other Expenses:

the Trade Date, Counterparty shall pay to Seller an amount equal to (a) the reasonable and documented attorney fees and other reasonable

and documented expenses related to such attorney fees incurred by Seller or its affiliates in connection with this Transaction and

(b) expenses actually incurred in connection with the acquisition of the Public Shares.

Settlement

Terms

Settlement

Method Election:

Not

Applicable.

Settlement

Method:

Physical

Settlement.

Settlement

Currency:

USD.

Settlement

Date:

Two

(2) Exchange Business Days following the Maturity Date.

Excess

Dividend Amount Ex

Amount.

Optional

Early Termination

From

time to time and on any Exchange Business Day following the closing of the Business Combination (any such date, an “OET

Date”), and subject to the terms and conditions below, Seller may, in its absolute discretion, terminate the Transaction

in whole or in part with respect to any number of Shares by giving notice of such termination and the specified number of Shares

(such quantity, the “Terminated Shares”). As of each OET Date, Counterparty shall be entitled to an amount from

Seller, and the Seller shall pay to Counterparty, an amount equal to the then in effect Reset Price, multiplied by (b) the Terminated

Shares. The Number of Shares shall be reduced by the number of Terminated Shares.

The

remainder of the Transaction, if any, shall continue in accordance with its terms; provided that if the OET Date is also the stated

Maturity Date, the remainder of the Transaction shall be settled in accordance with the other provisions of “Settlement Terms”.

Maturity

Consideration:

Maturity, in exchange for the return of the Number of Shares to Counterparty, Seller shall retain an amount equal to (i) the Number

of Shares multiplied by (ii) the Initial Price.

Maturity

Settlement:

The

Seller will retain the Maturity Consideration from the Prepayment Amount.

Adjustments:

Method

of Adjustment:

Calculation

Agent Adjustment.

Extraordinary

Events:

Consequences

of Merger Events involving Counterparty:

Share-for-Share:

Calculation

Agent Adjustment.

Share-for-Other:

Cancellation

and Payment.

Share-for-Combined:

Component

Adjustment.

Tender

Offer:

Applicable;

provided, however, that Section 12.1(d) of the Equity Definitions is hereby amended by adding “, or of the outstanding

Shares,” before “of the Issuer” in the fourth line thereof. Sections 12.1(e) and 12.1(l)(ii) of the Equity Definitions

are hereby amended by adding “or Shares, as applicable,” after “voting Shares”.

Consequences

of Tender Offers:

Share-for-Share:

Calculation

Agent Adjustment.

Share-for-Other:

Calculation

Agent Adjustment.

Share-for-Combined:

Calculation

Agent Adjustment.

Composition

of Combined Consideration:

Not

Applicable.

Nationalization,

Insolvency or Delisting:

Cancellation

and Payment (Calculation Agent Determination); provided that in addition to the provisions of Section 12.6(a)(iii) of the Equity

Definitions, it shall also constitute a Delisting if the Exchange is located in the United States and the Shares are not immediately

re-listed, re-traded or re-quoted on any of the New York Stock Exchange, the Nasdaq Global Select Market, Nasdaq Capital Market or

the Nasdaq Global Market (or their respective successors) or such other exchange or quotation system which, in the determination

of the Calculation Agent, has liquidity comparable to the aforementioned exchanges; if the Shares are immediately re-listed, re-traded

or re-quoted on any such exchange or quotation system, such exchange or quotation system shall be deemed to be the Exchange.

Business

Combination Exclusion:

Notwithstanding

the foregoing or any other provision herein, the parties agree that the Business Combination shall not constitute a Merger Event,

Tender Offer, Delisting or any other Extraordinary Event hereunder.

Additional

Disruption Events:

(a)

Change

in Law:

Applicable;

provided that Section 12.9(a)(ii) of the Equity Definitions is hereby amended by adding the words “(including, for the

avoidance of doubt and without limitation, adoption or promulgation of new regulations authorized or mandated by existing statute)”

after the word “regulation” in the second line thereof.

(a)

Failure

to Deliver:

Not

Applicable.

(b)

Insolvency

Filing:

Applicable.

(c)

Hedging

Disruption:

Not

Applicable.

(d)

Increased

Cost of Hedging:

Not

Applicable.

(e)

Loss

of Stock Borrow:

Not

Applicable.

(f)

Increased

Cost of Stock Borrow:

Not

Applicable.

Determining

Party:

For

all applicable events, Seller, unless (i) an Event of Default, Potential Event of Default or Termination Event has occurred and is

continuing with respect to Seller, or (ii) if Seller fails to perform its obligations as Determining Party, in which case a Third

Party Dealer (as defined below) in the relevant market selected by Counterparty will be the Determining Party.

Additional

Provisions:

Calculation

Agent:

Seller,

unless (i) an Event of Default, Potential Event of Default or Additional Termination Event has occurred and is continuing with respect

to Seller, or (ii) if Seller fails to perform its obligations as Calculation Agent, in which case an unaffiliated leading dealer

in the relevant market selected by Counterparty in its sole discretion will be the Calculation Agent.

the event that a party (the “Disputing Party”) does not agree with any determination made (or the failure to make

any determination) by the Calculation Agent, the Disputing Party shall have the right to require that the Calculation Agent have

such determination reviewed by a disinterested third party that is a dealer in derivatives of the type that is the subject of the

dispute and that is not an Affiliate of either party (a “Third Party Dealer”). Such Third Party Dealer shall be

jointly selected by the parties within one (1) Business Day after the Disputing Party’s exercise of its rights hereunder (once

selected, such Third Party Dealer shall be the “Substitute Calculation Agent”). If the parties are unable to agree

on a Substitute Calculation Agent within the prescribed time, each of the parties shall elect a Third Party Dealer and such two dealers

shall agree on a Third Party Dealer by the end of the subsequent Business Day. Such Third Party Dealer shall be deemed to be the

Substitute Calculation Agent. Any exercise by the Disputing Party of its rights hereunder must be in writing and shall be delivered

to the Calculation Agent not later than the third Business Day following the Business Day on which the Calculation Agent notifies

the Disputing Party of any determination made (or of the failure to make any determination). Any determination by the Substitute

Calculation Agent shall be binding in the absence of manifest error and shall be made as soon as possible but no later than the second

Business Day following the Substitute Calculation Agent’s appointment. The costs of such Substitute Calculation Agent shall

be borne by (a) the Disputing Party if the Substitute Calculation Agent substantially agrees with the Calculation Agent or (b) the

non- Disputing Party if the Substitute Calculation Agent does not substantially agree with the Calculation Agent. If, after following

the procedures and within the specified time frames set forth above, a binding determination is not achieved, the original determination

of the Calculation Agent shall apply.

Non-Reliance:

Applicable.

Agreements

and Acknowledgements Regarding Hedging Activities:

Applicable.

Additional

Acknowledgements:

Applicable.

Collateral

Provisions:

Grant

of Security Interest:

None.

Collateral:

None.

Securities

Account:

None.

Securities

Intermediary:

None.

Perfection:

None

Schedule

Provisions:

Specified

Entity:

relation to both Seller and Counterparty for the purpose of: Section 5(a)(v) [of the ISDA Form], Not Applicable Section 5(a)(vi)

[of the ISDA Form], Not Applicable Section 5(a)(vii) [of the ISDA Form], Not Applicable Section 5(b)(v) [of the ISDA Form], Not Applicable

Cross-Default

The

“Cross-Default” provisions of Section 5(a)(vi) of the ISDA Form will not apply to either party.

Credit

Event Upon Merger

The

“Credit Event Upon Merger” provisions of Section 5(b)(v) of the ISDA Form will not apply to either party.

Automatic

Early Termination:

The

“Automatic Early Termination” of Section 6(a) of the ISDA Form will not apply to either party.

Termination

Currency:

United

States Dollars.

Additional

Termination Event:

Will

apply to Seller and to Counterparty. The occurrence of any of the following events shall constitute an Additional Termination Event:

(a)

The Merger Agreement is terminated prior to the closing of the Business Combination; and

(b)

If it is, or, as a consequence of a change in law, regulation or interpretation, it becomes or will become, unlawful for the Seller

or Counterparty to perform any of its obligations contemplated by the Transaction; and

(c)

Upon the occurrence of any Material Adverse Change of the Counterparty.

Notwithstanding

the foregoing, Counterparty’s obligations set forth under the captions, “Reimbursement

of Legal Fees and Other Expenses,” and “Other Provisions — (d) Indemnification”

shall survive any termination due to the occurrence of either of the foregoing Additional

Termination Events. Upon any termination that occurs following the closing of the Business

Combination due to paragraph (b) or (c) above, Counterparty shall be obligated to promptly

accept for redemption all of Seller’s Recycled Shares in exchange for the Initial Price,

less any Prepayment Amount in respect of such Shares actually received. Except as set forth

in the immediately preceding sentence, in all other circumstances no further payments or

deliveries shall be due by either Seller to Counterparty or Counterparty to Seller in respect

of the Transaction, including without limitation in respect of any settlement amount, breakage

costs or any amounts representing the future value of the Transaction, and neither party

shall have any further obligation under the Transaction and, for the avoidance of doubt and

without limitation, no payments will have accrued or be due under Sections 2, 6 or 11 of

the ISDA Form.

Material

Adverse Change:

Means

any change, event, or occurrence, that, individually or when aggregated with other changes, events, or occurrences has had a materially

adverse effect on the business, assets, financial condition or results of operations of the Counterparty and its subsidiaries, taken

as a whole; provided, however, that no change, event, occurrence or effect arising out of or related to any of the following, alone

or in combination, shall be taken into account in determining whether a Material Adverse Change pursuant has occurred: (i) acts of

war (whether or not declared), sabotage, military or para-military actions or terrorism, or any escalation or worsening of any such

acts, or changes in global, national or regional political or social conditions; (ii) earthquakes, hurricanes, tornados, epidemics

and pandemics declared by the World Health Organization or any other reputable third party organization (including the COVID-19 virus)

or other natural or man-made disasters; (iii) changes attributable to the public announcement or pendency of the transactions contemplated

herein (including the impact thereof on relationships with customers, suppliers, employees or governmental authorities); (iv) changes

or proposed changes in law, regulations or interpretations thereof or decisions by courts or any governmental authority; (v) changes

or proposed changes in GAAP (or any interpretation thereof); (vi) any downturn in general economic conditions, including changes

in the credit, debt, securities, financial, capital or reinsurance markets (including changes in interest or exchange rates or the

price of any security, market index or commodity), in each case, in the United States or anywhere else in the world; (vii) events

or conditions generally affecting the industries and markets in which the Counterparty operates; (viii) any failure to meet any projections,

forecasts, estimates, budgets or financial or operating predictions of revenue, earnings, cash flow or cash position, provided that

this clause (viii) shall not prevent a determination that any change, event, or occurrence underlying such failure (unless otherwise

excluded by the other clauses of this proviso) has resulted in a Material Adverse Change; or (ix) any actions expressly required

to be taken, or expressly required not to be taken, pursuant to the terms hereof; provided, however, that if a change or effect related

to clause (ii) or clauses (iv) through (vii) disproportionately adversely affects the Counterparty and its subsidiaries, taken as

a whole, compared to other Persons operating in the same industry as the Counterparty, then such incremental disproportionate impact

may be taken into account in determining whether a Material Adverse Change has occurred.

Governing

Law:

New

York law (without reference to choice of law doctrine).

Credit

Support Document:

With

respect to Seller and Counterparty, None.

Credit

Support Provider:

With

respect to Seller and Counterparty, None.

Local

Business Days:

Seller

specifies the following places for the purposes of the definition of Local Business Day as it applies to it: New York.

Counterparty

specifies the following places for the purposes of the definition of Local Business Day as it applies to it: New York.

Representations,

Warranties and Covenants

Each

of Counterparty and Seller represents and warrants to, and covenants and agrees with, the other as of the date on which it enters

into the Transaction that (in the absence of any written agreement between the parties that expressly imposes affirmative obligations

to the contrary for the Transaction):

(a)

Non-Reliance.

It is acting for its own account, and it has made its own independent decisions to enter into the Transaction and as to whether

the Transaction is appropriate or proper for it based upon its own judgment and upon advice from such advisers as it has deemed necessary.

It is not relying on any communication (written or oral) of the other party as investment advice or as a recommendation to enter

into the Transaction, it being understood that information and explanations related to the terms and conditions of the Transaction

will not be considered investment advice or a recommendation to enter into the Transaction. No communication (written or oral) received

from the other party will be deemed to be an assurance or guarantee as to the expected results of the Transaction.

(b)

Assessment

and Understanding. It is capable of assessing the merits of and understanding (on its own behalf or through independent professional

advice), and understands and accepts, the terms, conditions and risks of the Transaction. It is also capable of assuming, and assumes,

the risks of the Transaction.

(c)

Non-Public

Information. It is in compliance with Section 10(b) under the Securities Exchange Act of 1934, as amended (the “Exchange

Act”).

(d)

Eligible

Contract Participant. It is an “eligible contract participant” under, and as defined in, the Commodity Exchange

Act (7 U.S.C. § 1a(18)) and CFTC regulations (17 CFR § 1.3).

(e)

Tax

Characterization. It shall treat the Transaction as a derivative financial contract for U.S. federal income tax purposes,

and it shall not take any action or tax return filing position contrary to this characterization.

(f)

Private

Placement. It (i) is an “accredited investor” as such term is defined in Regulation D as promulgated under the

Securities Act, (ii) is entering into the Transaction for its own account without a view to the distribution or resale thereof and

(iii) understands that the assignment, transfer or other disposition of the Transaction has not been and will not be registered under

the Securities Act.

(g)

Investment

Company Act. It is not and, after giving effect to the Transaction, will not be required to register as an “investment

company” under, and as such term is defined in, the Investment Company Act of 1940, as amended.

(h)

Authorization.

The Transaction has been entered into pursuant to authority granted by its board of directors or other governing authority. It

has no internal policy, whether written or oral, that would prohibit it from entering into any aspect of the Transaction, including,

but not limited to, the purchase of Shares to be made in connection therewith.

(i)

Affiliate

Status. It is the intention of the parties hereto that Seller shall not be an “affiliate”

(as such term is defined in Rule 405 under the Securities Act) of the Counterparty, including

Target following the closing of the Business Combination, as a result of the transactions

contemplated hereunder

(j)

Tender

Offer Rules. Counterparty, Target and Seller each acknowledge that the Transaction has been structured, and all activity

in connection with the Transaction has been undertaken to comply with the requirements of all tender offer regulations applicable

to the Business Combination, including Rule 14e-5 under the Exchange Act.

(k)

Enforceability.

The Transaction, including the Confirmation, when executed and delivered by each of the parties, will constitute the valid and

legally binding obligation of each such party, enforceable against each of them in accordance with its terms, except (i) as limited

by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general application

affecting enforcement of creditors’ rights generally, or (ii) as limited by laws relating to the availability of specific performance,

injunctive relief or other equitable remedies.

(l)

Compliance

with Other Instruments and Law. The execution, delivery and performance of this Transaction, including the Confirmation,

and the consummation of the Transaction, will not result in any violation or default (i) of any provisions of its organizational

documents, (ii) of any instrument, judgment, order, writ or decree to which it is a party or by which it is bound, (iii) under any

note, indenture or mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement, contract or purchase

order to which it is a party or by which it is bound or (v) of any provision of any applicable federal or state statute, rule or

regulation, in each case (other than clause (i)), which would have a material adverse effect on it or its ability to consummate the

Transaction.

Counterparty

represents and warrants to, and covenants and agrees with Seller as of the date on which it enters into the Transaction that:

(a)

Non-Reliance.

Without limiting the generality of Section 13.1 of the Equity Definitions, Counterparty acknowledges that Seller is not making

any representations or warranties or taking any position or expressing any view with respect to the treatment of the Transaction

under any accounting standards.

(b)

Solvency.

Counterparty is, and shall be as of the date of any payment or delivery by Counterparty under the Transaction, solvent and able to

pay its debts as they come due, with assets having a fair value greater than liabilities and with capital sufficient to carry on

the businesses in which it engages. Counterparty: (i) has not engaged in and will not engage in any business or transaction after

which the property remaining with it will be unreasonably small in relation to its business, (ii) has not incurred and does not intend

to incur debts beyond its ability to pay as they mature, and (iii) as a result of entering into and performing its obligations under

the Transaction, (a) it has not violated and will not violate any relevant state law provision applicable to the acquisition or redemption

by an issuer of its own securities and (b) it would not be nor would it be rendered “insolvent” (as such term is defined

under Section 101(32) of the Bankruptcy Code).

(c)

Public

Reports. As of the Trade Date, Counterparty is in material compliance with its reporting obligations under the Exchange Act,

and all reports and other documents filed by Counterparty with the Securities and Exchange Commission pursuant to the Exchange Act,

when considered as a whole (with the most recent such reports and documents deemed to amend inconsistent statements contained in

any earlier such reports and documents), do not contain any untrue statement of a material fact or any omission of a material fact

required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were

made, not misleading.

(d)

Distribution. Counterparty is not entering into the Transaction to facilitate a distribution of the Shares (or any security

that may be converted into or exercised or exchanged for Shares, or whose value under its terms may in whole or in significant part

be determined by the value of the Shares) or in connection with any future issuance of securities.

(e)

[Reserved.]

(f)

Waiver.

The Counterparty shall waive any violation of its “bulldog clause” and any other restrictions that would be caused by

Seller entering into this Transaction.

(g)

Disclosure.

The Counterparty agrees to comply with applicable SEC guidance in respect of disclosure and

the Counterparty shall preview with Seller all public disclosure relating to the Transaction

and shall consult with Seller to ensure that such public disclosure, including the press

release, Form 8-K or other filing that announces the Transaction adequately discloses the

material terms and conditions of the Transaction in form and substance reasonably acceptable

to Seller; provided that the Form 8-K shall be publicly filed on the same date that definitive

transaction documents are signed

(h)

Regulation

M and Target Approvals. Counterparty is not on the Trade Date and agrees and covenants

that it will not be on any date Seller is purchasing shares that may be included in a Pricing

Date Notice, engaged or engaging in a distribution, as such term is used in Regulation M

under the Exchange Act, of any securities of Counterparty, other than a distribution meeting

the requirements of the exception set forth in Rules 101(b)(10) and 102(b)(7) of Regulation

M. Counterparty shall not, until the second scheduled trading day immediately following the

dates referenced in the preceding sentence, engage in any such distribution. Counterparty,

including Target, also agrees and covenants that the Merger Agreement shall be executed and

all required approvals and consents of the Target security holders in connection with the

Business Combination shall be obtained and any subsequent valuation periods as contemplated

under Regulation M under the Exchange Act, shall be completed in each case no later than

Counterparty’s redemption deadline.

(i)

conflicts. The execution and delivery by the Counterparty and Target of, and the performance by the Counterparty and the

Target of its obligations under, the Transaction and the Confirmation and the consummation of the transactions contemplated by the

Confirmation, including the payments and share issuances hereunder, do not and will not result in any breach or violation of or constitute

a default under (nor constitute any event which, with notice, lapse of time or both, would result in any breach or violation of or

constitute a default under or give the holder of any indebtedness (or a person acting on such holder’s behalf) the right to

require the repurchase, redemption or repayment of all or a part of such indebtedness under) (or result in the creation or imposition

of a lien, charge or encumbrance on any property or assets of the Counterparty, the Target or any of their respective subsidiaries

pursuant to) (i) any provision of applicable law, (ii) the organizational documents of any of the Counterparty, the Target or any

of their respective subsidiaries, (iii) any indenture, mortgage, deed of trust, bank loan or credit agreement or other evidence of

indebtedness, or any license, lease, contract or other agreement or instrument binding upon the Counterparty, the Target or any of

their respective subsidiaries, or (iv) any judgment, order or decree of any governmental body, agency or court having jurisdiction

over the Counterparty, the Target or any of their respective subsidiaries, and no consent, approval, authorization or order of, or

qualification with, any governmental body or agency is required for the performance by the Counterparty or the Target of their respective

obligations under the Confirmation, except as have been obtained. In addition, the Counterparty and Target covenant and agree not

to enter into any agreement or other arrangement that would prohibit, restrict or otherwise prevent the Counterparty from performing

its obligations hereunder, including the making of any payment or Share issuance to the Seller.

Seller

represents and warrants to, and covenants and agrees with Counterparty as of the date on which it enters into the Transaction and

each other date specified that:

(a)

Regulatory

Filings. It, together with each other person in the Seller Group (as defined in “Other Provisions” below), is

in compliance with all material regulatory filings relating to the Counterparty and the Transaction. Seller covenants that it will

make all regulatory filings that it is required by law or regulation to make with respect to the Transaction including, without limitation,

as may be required by Section 13 or Section 16 under the Exchange Act.

(b)

Shareholder

Vote. Seller agrees to not vote any Shares it holds as of the applicable record date in connection with the Business Combination

at any meeting of the Counterparty’s shareholders (or to provide a written consent for that purpose with respect to such Shares)

if it would be in violation of Interpretation 166.01 to do so.

(c)

Private

Placement. Seller (i) is an “accredited investor” as such term is defined in Regulation D as promulgated under

the Securities Act, (ii) is entering into the Transaction for its own account without a view to the distribution or resale thereof

and (iii) understands that the assignment, transfer or other disposition of the Transaction has not been and will not be registered

under the Securities Act.

Transactions

by Seller in the Shares

Seller

hereby waives the redemption rights (“Redemption Rights”) set forth in Counterparty’s memorandum and articles

of association in connection with the Business Combination with respect to the Public Shares save for any redemption following the Additional

Termination Events set out in (c) and (d) in the Additional Termination Event section above. Unless specified in an OET Notice, no sale

of Shares by the Seller shall terminate all or any portion of this Confirmation and provided that Seller complies with all of its other

obligations hereunder nothing contained herein shall limit any of Seller’s purchases and sale of Shares

Arrangements

Seller

and Counterparty each acknowledge and agree that: (i) there are no voting, hedging or settlement arrangements between Seller and Counterparty

with respect to any Shares, other than those set forth herein; (ii) Counterparty will not be entitled to any voting rights in respect

of any of the Shares underlying the Transaction; and (iii) Counterparty will not seek to influence Seller with respect to the voting

of any Hedge Positions of Seller consisting of Shares.

Wall

Street Transparency and Accountability Act

connection with Section 739 of the Wall Street Transparency and Accountability Act of 2010 (“WSTAA”), the parties

hereby agree that neither the enactment of WSTAA or any regulation under WSTAA, nor any requirement under WSTAA or an amendment made

by WSTAA, nor any similar legal certainty provision in any legislation enacted, or rule or regulation promulgated, on or after the date

of this Confirmation, shall limit or otherwise impair either party’s otherwise applicable rights to terminate, renegotiate, modify,

amend or supplement this Confirmation or the ISDA Form, as applicable, arising from a termination event, force majeure, illegality, increased

costs, regulatory change or similar event under this Confirmation, the Equity Definitions incorporated herein, or the ISDA Form.

Address

for Notices

Notice

to Seller:

Harraden

Circle Investments LLC

885

Third Avenue , Suite 2600B

New

York, NY 10022

Attention:

Frederick V. Fortmiller, Jr.

Email:

research@harraden.com

With

a mandatory copy (which shall not constitute notice) to:

Loeb

& Loeb LLP

345

Park Avenue

New

York, NY 10154

Attn:

Giovanni Caruso

Telephone

No.: (212) 407-4866

Email:

gcaruso@loeb.com

Notice

to Counterparty:

Calisa

Acquisition Corp

205

W. 37th Street

New

York, New York 10018

Attention:

Hongfei Zhang

Email:

hongfei.zhang@calisaspac.com

with

copies (which shall not constitute notice) to:

Graubard

Miller

The

Chrysler Building

405

Lexington Avenue

New

York, NY 10174

Attention:

Jeffrey M. Gallant, David Alan Miller

Email:

jgallant@graubard.com, dmiller@graubard.com

Notice

to Target:

Goodvision

AI Inc.

4430

Bush Cir

Fremont,

CA 94538

Attention:

Davy Wong

Email:

davy@goodvision.tech

with

copies (which shall not constitute notice) to:

VCL

Law LLP

1945

Old Gallows Road, Suite 260

Vienna,

VA 22182

Attention:

Fang Liu, Zixuan Guo

Email:

fliu@vcllegal.com, zguo@vcllegal.com

Other

Provisions.

(a)

Rule

10b5-1.

(i)

Counterparty

represents and warrants to Seller that Counterparty is not entering into the Transaction to create actual or apparent trading activity

in the Shares (or any security convertible into or exchangeable for the Shares) or to raise or depress or otherwise manipulate the

price of the Shares (or any security convertible into or exchangeable for the Shares) for the purpose of inducing the purchase or

sale of such securities or otherwise in violation of the Exchange Act, and Counterparty represents and warrants to Seller that Counterparty

has not entered into or altered, and agrees that Counterparty will not enter into or alter, any corresponding or hedging transaction

or position with respect to the Shares. Counterparty acknowledges that it is the intent of the parties that the Transaction comply

with the requirements of paragraphs (c)(1)(i)(A) and (B) of Rule 10b5-1 under the Exchange Act (“Rule 10b5-1”)

and the Transaction shall be interpreted to comply with the requirements of Rule 10b5-1(c).

(ii)

Counterparty

agrees that it will not seek to control or influence Seller’s decision to make any “purchases or sales” (within

the meaning of Rule 10b5-1(c)(1)(i)(B)(3)) under the Transaction, including, without limitation, Seller’s decision to enter

into any hedging transactions. Counterparty represents and warrants that it has consulted with its own advisors as to the legal aspects

of its adoption and implementation of this Confirmation and the Transaction under Rule 10b5-1.

(iii)

Counterparty

acknowledges and agrees that any amendment, modification, waiver or termination of this Confirmation must be effected in accordance

with the requirements for the amendment or termination of a “plan” as defined in Rule 10b5-1(c). Without limiting the

generality of the foregoing, Counterparty acknowledges and agrees that any such amendment, modification, waiver or termination shall

be made in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b-5, and no such amendment, modification

or waiver shall be made at any time at which Counterparty, or any officer, director, manager or similar person of Counterparty is

aware of any material non-public information regarding Counterparty or the Shares.

(b)

[Reserved.]

(c)

Transfer

or Assignment. The rights and duties under this Confirmation may not be transferred or assigned by any party hereto without

the prior written consent of the other party, such consent not to be unreasonably withheld, subject to the immediately following

sentence. If at any time following the closing of the Business Combination at which (A) the Section 16 Percentage exceeds 9.9%, or

(B) the Share Amount exceeds the Applicable Share Limit (if any applies) (any such condition described in clause (A) or (B), an “Excess

Ownership Position”), Seller is unable to effect a transfer or assignment of a portion of the Transaction to a third party

on pricing terms reasonably acceptable to Seller and within a time period reasonably acceptable to Seller such that no Excess Ownership

Position exists, then Seller may designate any Exchange Business Day as an Early Termination Date with respect to a portion of the

Transaction (the “Terminated Portion”), such that following such partial termination no Excess Ownership Position

exists. In the event that Seller so designates an Early Termination Date with respect to a portion of the Transaction, a portion

of the Shares with respect to the Transaction shall be delivered to Counterparty and Counterparty shall be obligated to promptly

accept for redemption all of Seller’s Shares in exchange for the Initial Price. The “Section 16 Percentage”

as of any day is the fraction, expressed as a percentage, as determined by Seller, (A) the numerator of which is the number of Shares

that Seller and each person subject to aggregation of Shares with Seller under Section 13 or Section 16 of the Exchange Act and rules

promulgated thereunder and all persons who may form a “group” (within the meaning of Rule 13d-5(b)(1) of the Exchange

Act) with Seller directly or indirectly beneficially own (as defined under Section 13 or Section 16 of the Exchange Act and rules

promulgated thereunder) (the “Seller Group” ) and (B) the denominator of which is the number of Shares outstanding.

The

“Share Amount” as of any day is the number of Shares that Seller and any person whose ownership position would be

aggregated with that of Seller and any group (however designated) of which Seller is a member (Seller or any such person or group, a

“Seller Person”) under any law, rule, regulation, regulatory order or organizational documents or contracts of Counterparty

that are, in each case, applicable to ownership of Shares (“Applicable Restrictions”), owns, beneficially owns, constructively

owns, controls, holds the power to vote or otherwise meets a relevant definition of ownership under any Applicable Restriction, as determined

by Seller in its sole discretion.

The

“Applicable Share Limit” means a number of Shares equal to (A) the minimum number of Shares that could give rise to

reporting or registration obligations or other requirements under Section 16 of the Exchange Act including obtaining prior approval from

any person or entity) of a Seller Person, or could result in an adverse effect on a Seller Person, under any Applicable Restriction,

as determined by Seller in its sole discretion, minus (B) 0.1% of the number of Shares outstanding.

(d)

Indemnification.

Counterparty agrees to indemnify and hold harmless Seller, its affiliates and its assignees and their respective directors, officers,

employees, agents and controlling persons (each such person being an “Indemnified Party”) from and against any

and all losses (but not including financial losses to an Indemnified Party relating to the economic terms of the Transaction provided

that the Counterparty performs its obligations under this Confirmation in accordance with its terms), claims, damages and liabilities

(or actions in respect thereof), joint or several, incurred by or asserted against such Indemnified Party arising out of, in connection

with, or relating to, the execution or delivery of this Confirmation, the performance by Counterparty of its obligations under the

Transaction, any breach of any covenant or representation made by Counterparty in this Confirmation or the ISDA Form, regulatory

filings made by Counterparty related to the Transaction (other than as relates to any information provided by or on behalf of Seller

or its affiliates), or the consummation of the transactions contemplated hereby; provided, however, that Counterparty has no indemnification

obligations with respect to any loss, claim, damage, liability or expense related to the manner in which Seller sells, or arising

out of any sales by Seller of, any Shares owned by Seller. Counterparty will not be liable under the foregoing indemnification provision

to the extent that any loss, claim, damage, liability or expense is found in a nonappealable judgment by a court of competent jurisdiction

to have resulted from Seller’s material breach of any covenant, representation or other obligation in this Confirmation or

the ISDA Form or from Seller’s willful misconduct, gross negligence or bad faith in performing the services that are subject

of the Transaction. If for any reason the foregoing indemnification is unavailable to any Indemnified Party or insufficient to hold

harmless any Indemnified Party, then Counterparty shall contribute, to the maximum extent permitted by law, to the amount paid or

payable by the Indemnified Party as a result of such loss, claim, damage or liability. In addition (and in addition to any other

Reimbursement of Legal Fees and other Expenses contemplated by this Confirmation), Counterparty will reimburse any Indemnified Party

for all reasonable, out-of-pocket, expenses (including reasonable counsel fees and expenses) as they are incurred in connection with

the investigation of, preparation for or defense or settlement of any pending or threatened claim or any action, suit or proceeding

arising therefrom, whether or not such Indemnified Party is a party thereto and whether or not such claim, action, suit or proceeding

is initiated or brought by or on behalf of Counterparty. Counterparty also agrees that no Indemnified Party shall have any liability

to Counterparty or any person asserting claims on behalf of or in right of Counterparty in connection with or as a result of any

matter referred to in this Confirmation except to the extent that any losses, claims, damages, liabilities or expenses incurred by

Counterparty result from such Indemnified Party’s breach of any covenant, representation or other obligation in this Confirmation

or the ISDA Form or from the gross negligence, willful misconduct or bad faith of the Indemnified Party or breach of any U.S. federal

or state securities laws or the rules, regulations or applicable interpretations of the Securities and Exchange Commission. The provisions

of this paragraph shall survive the completion of the Transaction contemplated by this Confirmation and any assignment and/or delegation

of the Transaction made pursuant to the ISDA Form or this Confirmation shall inure to the benefit of any permitted assignee of Seller.

(e)

Amendments

to Equity Definitions.

(i)

Section

11.2(a) of the Equity Definitions is hereby amended by (i) replacing the words “a diluting or concentrative” with the

word “an” and adding the phrase “or such Transaction” at the end thereof;

(ii)

The

first sentence of Section 11.2(c) of the Equity Definitions, prior to clause (A) thereof, is hereby amended to read as follows: ‘(c)

If “Calculation Agent Adjustment” is specified as the Method of Adjustment in the related Confirmation of a Share Option

Transaction or Share Forward Transaction, then, following the announcement or occurrence of any Potential Adjustment Event, the Calculation

Agent will determine whether such Potential Adjustment Event has an economic effect on the Transaction and, if so, will (i) make

appropriate adjustment(s), if any, to any one or more of:’ and the portion of such sentence immediately preceding clause (ii)

thereof is hereby amended by deleting the words “diluting or concentrative”.

(iii)

Section

11.2(e)(vii) of the Equity Definitions is hereby amended by (i) replacing the words “a diluting or concentrative” with

the word “an” and (ii) adding the phrase “or the relevant Transaction” at the end thereof;

(iv)

Section

12.6(a)(ii) of the Equity Definitions is hereby amended by (i) deleting from the fourth line thereof the word “or” after

the word “official” and inserting a comma therefor, and (ii) deleting the semi-colon at the end of subsection (B) thereof

and inserting the following words therefor “or (C) the occurrence of any of the events specified in Section 5(a)(vii)(1) through

(9) of the ISDA Form with respect to that Issuer”;

(v)

Section

12.6(c)(ii) of the Equity Definitions is hereby amended by replacing the words “the Transaction will be cancelled,” in

the first line with the words “Seller will have the right, which it must exercise or refrain from exercising, as applicable,

in good faith acting in a commercially reasonable manner, to cancel the Transaction,”; and

(vi)

Section

12.9(b)(i) of the Equity Definitions is hereby amended by (i) replacing “either party may elect” with “Seller may

elect” and (ii) replacing “notice to the other party” with “notice to Counterparty” in the first sentence

of such section.

(f)

Waiver

of Jury Trial. Each party waives, to the fullest extent permitted by applicable law, any right it may have to a trial by

jury in respect of any suit, action or proceeding relating to the Transaction. Each party (i) certifies that no representative, agent

or attorney of either party has represented, expressly or otherwise, that such other party would not, in the event of such a suit,

action or proceeding, seek to enforce the foregoing waiver and (ii) acknowledges that it and the other party have been induced to

enter into the Transaction, as applicable, by, among other things, the mutual waivers and certifications provided herein.

(g)

Attorney

and Other Fees. In the event of any legal action initiated by any party arising under or out of, in connection with or in

respect of, this Confirmation or the Transaction, the prevailing party shall be entitled to reasonable attorneys’ fees, costs

and expenses incurred in such action, as determined and fixed by the court.

(h)

Tax

Disclosure. Effective from the date of commencement of discussions concerning the Transaction, Counterparty and each of its

employees, representatives, or other agents may disclose to any and all persons, without limitation of any kind, the tax treatment

and tax structure of the Transaction and all materials of any kind (including opinions or other tax analyses) that are provided to

Counterparty relating to such tax treatment and tax structure.

(i)

Securities

Contract; Swap Agreement. The parties hereto intend for (i) the Transaction to be (a) a “securities contract”

as defined in the Bankruptcy Code, in which case each payment and delivery made pursuant to the Transaction is a “termination

value,” “payment amount” or “other transfer obligation” within the meaning of Section 362 of the Bankruptcy

Code and a “settlement payment,” within the meaning of Section 546 of the Bankruptcy Code, and (b) a “swap agreement”

as defined in the Bankruptcy Code, with respect to which each payment and delivery hereunder or in connection herewith is a “termination

value,” “payment amount” or “other transfer obligation” within the meaning of Section 362 of the Bankruptcy

Code and a “transfer,” as such term is defined in Section 101(54) of the Bankruptcy Code and a “payment or other

transfer of property” within the meaning of Sections 362 and 546 of the Bankruptcy Code, and the parties hereto to be entitled

to the protections afforded by, among other Sections, Sections 362(b)(6), 362(b)(17), 546(e), 546(g), 555 and 560 of the Bankruptcy

Code, (ii) a party’s right to liquidate, terminate and accelerate the Transaction and to exercise any other remedies upon the

occurrence of any Event of Default under the ISDA Form with respect to the other party to constitute a “contractual right”

as described in the Bankruptcy Code, and (iii) each payment and delivery of cash, securities or other property hereunder to otherwise

constitute a “margin payment” or “settlement payment” and a “transfer” as defined in the Bankruptcy

Code.

(i)

Process

Agent. For the purposes of Section 13(c) of the ISDA Form:

Seller

appoints as its Process Agent: None

Counterparty

appoints as its Process Agent: None.

[Signature

page follows]

Please

confirm that the foregoing correctly sets forth the terms of our agreement by executing a copy of this Confirmation and returning it

to us at your earliest convenience.

Very

truly yours,

By:

/s/

Frederick V. Fortmiller

Name:

Frederick

V. Fortmiller

Title:

Authorized

Signatory

Agreed

and accepted by:

Calisa

Acquisition Corp.

By:

/s/

Hongfei Zhang

Name:

Hongfei

Zhang

Title:

Chairman

Goodvision

AI Inc.

By:

/s/

Yi Wang

Name:

Wang

Title:

CEO

SCHEDULE

FORM

OF PRICING DATE NOTICE

Date:

September

[*], 2026

To:

Calisa

Acquisition Corp, a Cayman Islands exempted company (“Counterparty”)

Address:

Phone:

From:

Harraden

Circle Investors, LP, Harraden Circle Special Opportunities, LP, Harraden Circle Strategic Investments, LP (collectively “Seller”)

Re:

OTC

Equity Prepaid Forward Transaction

This

Pricing Date Notice supplements, forms part of, and is subject to the Confirmation Re: Prepaid Share Forward Transaction, dated as

of August [*], 2026 (the “Confirmation”), between Counterparty and Seller, as amended and supplemented from time

to time. All provisions contained in the Confirmation govern this Pricing Date Notice except as expressly modified below.

The

purpose of this Pricing Date Notice is to confirm certain terms and conditions relating to the transaction described in the Confirmation.

Pricing

Date: September [*], 2026

Number

of Recycled Shares: [ ]

Number

of Shares: [____]

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 19

v3.26.3

Cover

Sep. 15, 2026

Document Type

8-K

Amendment Flag

false

Document Period End Date

Sep. 15, 2026

Entity File Number

001-42910

Entity Registrant Name

CALISA

ACQUISITION CORP

Entity Central Index Key

0002026767

Entity Tax Identification Number

00-0000000

Entity Incorporation, State or Country Code

Entity Address, Address Line One

205

W. 37th Street

Entity Address, City or Town

New

York

Entity Address, State or Province

Entity Address, Postal Zip Code

10018

City Area Code

(203)

Local Phone Number

998-5540

Written Communications

true

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

Units, each consisting of one ordinary share and one right

Title of 12(b) Security

Units,

each consisting of one ordinary share and one right

Trading Symbol

ALISU

Security Exchange Name

NASDAQ

Ordinary Shares, par value $0.000075 per share

Title of 12(b) Security

Ordinary

Shares, par value $0.000075 per share

Trading Symbol

ALIS

Security Exchange Name

NASDAQ

Rights, each entitling the holder to one tenth of one ordinary share upon the completion of the Company’s initial business combination

Title of 12(b) Security

Rights,

each entitling the holder to one tenth of one ordinary share upon the completion of the Company’s initial business combination

Trading Symbol

ALISR

Security Exchange Name

NASDAQ

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=ALIS_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=ALIS_OrdinarySharesParValue0.000075PerShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=ALIS_RightsEachEntitlingHolderToOneTenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: